The Maudsley bipolar disorder project. A survey of psychotropic prescribing patterns in bipolar I disorder

Bipolar Disorders

Volumn 4, Issue 6, 2002, Pages 378-385

  Frangou, Sophia ^a   Raymont, Vanessa ^a   Bettany, David ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bipolar disorder; Prescriptions; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR I DISORDER; CLINICAL FEATURE; DRUG USE; FEMALE; GENDER; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MEDICAL DECISION MAKING; MEDICAL RECORD; MONOTHERAPY; NATIONAL HEALTH SERVICE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ADULT; BIPOLAR DISORDER; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME;

EID: 0036926267     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2002.01223.x     Document Type: Article

References (49)

1. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York: Oxford University Press, 1990.
2. Coryell W, Scheftner W, Keller M, Endicott J, Maser J, Klerman GL. The enduring psychosocial consequences of mania and depression. Am J Psychiatry 1993; 150: 720-727.
3. Zarate CA, Tohen M, Land M, Cavanagh S. Functional impairment and cognition in bipolar disorder. Psychiatr Q 2000; 71: 309-329.
4. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Medical 2000; Spec No: 1-104.
5. Goodwin GM, Nolen WA. Treatment of bipolar depressive mood disorders: algorithms for pharmacotherapy. Int J Psychiatr Clin Practice 2001; 1: 9-12.
6. American Psychiatric Association. Practice guidelines for the treatment of patients with bipolar disorder. Am J Psychiatry 1994; 151: 1-36.
7. Sachs GS, Thase ME. Bipolar disorder therapeutics: maintenance treatment. Biol Psychiatry 2000; 48: 573-581.
8. Lim PZ, Tunis SL, Edell WS, Jensik SE, Tohen M. Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines. Bipolar Disord 2001; 3: 165-173.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. (DSM-IV) Washington, DC: APA, 1994.
10. Taylor D, Kerwin R. Maudsley Prescribing Guidelines. London: Martin Dunitz, 1999.
11. Cotterchio M, Kreiger N, Darlington G, Steingart A. Comparison of self-reported and physician-reported anti-depressant medication use. Ann Epidemiol 1999; 9: 283-289.
12. Monson RA, Bond CA. The accuracy of the medical record as an index of outpatient drug therapy. JAMA 1978; 240: 2182-2184.
13. Wagner MM, Hogan WR. The accuracy of medication data in an outpatient electronic medical record. J Am Med Inform Assoc 1996; 3: 234-244.
14. Glover GR, Robin E, Emami J, Arabscheibani GR. A needs index for mental health care. Soc Psychiatry Psychiatr Epidemiol 1998; 33: 89-96.
15. Jarman B. Identification of underprivileged areas. BMJ 1983; 286: 1705-1709.
16. King's Fund London Commission. London's Mental Health. Johnson S et al. ed. London: King's Fund, 1997; p. 26.
17. Jones PB, Bebbington P, Foerster A et al. Premorbid social underachievement in schizophrenia. Results from the Camberwell Collaborative Psychosis Study. Br J Psychiatry 1993; 162: 65-71.
18. Thornicroft G, Strathdee G, Phelan M, et al. Rationale and design. PRISM psychosis study I. Br J Psychiatry 1998; 173: 363-370.
19. Maj M, Pirozzi R, Magliano L, Bartoli L. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Am J Psychiatry 1998; 155: 30-35.
20. Bowden CL, Calabrese JR, Mcelroy SL et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group Arch General Psychiatry 2000; 57: 481-489.
21. Peselow ED, Fieve RR, Difiglia C, Sanfilipo MP. Lithium prophylaxis of bipolar illness. The value of combination treatment. Br J Psychiatry 1994; 164: 208-214.
22. Johnson RE, McFarland BH. Lithium use and discontinuation in a health maintenance organization. Am J Psychiatry 1996; 153: 993-1000.
23. Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology 2000; 42 (Suppl. 1): 2-10.
24. Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ. Predictors of response to mood stabilizers. J Clin Psychopharmacol 1996; 16: 24S-31S.
25. Ghadirian AM, Annable L, Belanger MC. Lithium, benzodiazepines, and sexual function in bipolar patients. Am J Psychiatry 1992; 149: 801-815.
26. Aizenberg D, Sigler M, Zemishlany Z, Weizman A. Lithium and male sexual function in affective patients. Clin Neuropharmacol 1996; 19: 515-519.
27. Frangou S, Lewis M. Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London service. Eur Psychiatry 2000; 15: 220-226.
28. Collaborative Working Group on Clinical Trial Evaluations. Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. J Clin Psychiatry 1998; 59 (Suppl. 12): 41-45.
29. Keks NA, Altson K, Hope J et al. Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service. Aust N Z J Psychiatry 1999; 33: 896-901.
30. Tohen M, Zarate CA Jr. Antipsychotic agents and bipolar disorder. J Clin Psychiatry 1998; 59 (Suppl. 1): 38-48.
31. Sernyak MJ, Godleski LS, Griffin RA, Mazure CM, Woods SW. Chronic neuroleptic exposure in bipolar out-patients. J Clin Psychiatry 1997; 58: 193-195.
32. Keck PE, Mcelroy SL, Strakowski SM, Balistreri TM, Kizer DI, West SA. Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder. J Clin Psychiatry 1996; 57: 147-151.
33. Zarate CA, Tohen M. Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study. J Clin Psychiatry 2000; 61: 33-38.
34. Soares JC, Barwell M, Mallinger AG, Kupfer DJ, Frank E. Adjunctive antipsychotic use in bipolar patients: an open 6-month prospective study following an acute episode. J Affect Disord 1999; 56: 1-8.
35. Licht RW, Gouliaev G, Vestergaard P, Dybbro J, Lund H, Merinder L. Treatment of manic episodes in Scandinavia: the use of neuroleptic drugs in a clinical routine setting. J Affect Disord 1994; 32: 179-185.
36. Verdoux H, Gonzales B, Takei N, Bourgeois M. A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients. J Affect Disord 1996; 38: 81-87.
37. Levine J, Chengappa KN, Brar JS, Gershon S, Kupfer DJ. Illness characteristics and their association with prescription patterns for bipolar I disorder. Bipolar Discord 2001; 3: 41-49.
38. Tohen M, Tsuang MT, Goodwin DC. Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features. Am J Psychiatry 1992; 149: 1580-1584.
39. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch General Psychiatry 1979; 316; 555-559.
40. Akiskal HS, Mallya G. Criteria for the 'soft' bipolar spectrum: treatment implications. Psychopharmacol Bull 1987; 23: 68-73.
41. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994; 164: 549-550.
42. Moller HJ, Grunze H. Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci 2000; 250: 57-68.
43. Angst J. Switch from depression to mania-a record study over decades between 1920 and 1982. Psychopathology 1985; 18: 140-154.
44. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144: 1403-1411.
45. Altshuler L, Kiriakos L, Calcagno J et al. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry 2001; 62: 612-616.
46. Strakowski SMI, Bello MP, Fleck DE, Arndt S. The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry 2000; 48: 477-485.
47. Kupfer DJ, Frank E, Grochocinski VJ, Cluss PA, Houck PR, Stapf DA. Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry 2002; 63: 120-125.
48. Frye MA, Ketter TA, Leverich GS et al. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000; 61: 9-15.
49. Moncrieff J. Lithium revisited. A re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder. Br J Psychiatry 1995; 167: 569-573.